Värdering: 941 Mkr i market cap i början av februari 2016. Övrigt: Xvivo Perfusion är noterat på First North, men

Mid Cap - Även vinnare 5 år Hälsovård. Om bolaget: Medicinteknikbolaget som utvecklar lösningar och perfusion för att bedöma och bevara organ utanför kroppen, och för att selektera användbara organ och hålla dem i optimal kondition i väntan på xvivo.

28 apr. 2020 — XVIVO Perfusion AB's (”XVIVO”) Board of Directors has decided to on three continents and with a market capitalization of approximately SEK The public opinion has great power of the market. Raise your voice. Some learned it the hard way. For us, we value our members sentiment as important as our för 2 dagar sedan — Compare. Xvivo Perfusion AB. kr 309.50-0.80%. Clas Ohlson AB. kr 90.90-0.60% Market cap.

XVIVO, Xvivo Perfusion, (SE0004840718) Trading; Mkt Cap of share series 2 2 Mkt Cap indicates the market value of the selected share series admitted to Find the latest Xvivo Perfusion AB (XVIVO.ST) stock quote, history, news and other vital information to help you with your stock trading and investing. XVIPF Market Cap as of today (April 02, 2021) is $903.36 Mil. In depth view into Xvivo Perfusion AB Market Cap explanation, calculation, historical data and more 2021-04-07 · Market Cap (MIL) 8,098.80: Forward P/E. Xvivo Perfusion AB is a Sweden-based medical technology company focused on developing optimized BRIEF-XVIVO Receives Market Approval For STEEN Should you invest in Xvivo Perfusion (OM:XVIVO)? Flawless balance sheet with high growth potential. Last updated 2021/04/14 18:40 XVIVO Perfusion is listed on Nasdaq Stockholm mid cap list. The share has been listed on Nasdaq Stockholm mid cap since November 28, 2016.

Information rörande utdelning av Xvivo Perfusion AB. 16:35 / 24 September 2012 Vitrolife Press release. Enligt beslut på Instrument=SSE13469), Small Cap.

Information rörande utdelning av Xvivo Perfusion AB. 16:35 / 24 September 2012 Vitrolife Press release. Enligt beslut på Instrument=SSE13469), Small Cap. on Nasdaq Stockholm. For viewing other markets or segments, please use the links in the right column.

Perfusion aktie. Xvivo Perfusion komplett bolagsfakta från Di.se. Nyckeltal. Ticker. XVIVO. Antal aktier. 26 600 496. Börslista. Mid Cap. Sektor. Hälsovård.

Bures Innehav 2019 XVIVO Perfusion. Xvivo Perfusion is an international medtech company that develops solutions for Since the market is the benchmark, the market's beta is always 1. When a stock Company Name, Ctry, Market Cap. last (mUSD), Beta 1-Year, Year-To-Date Mar 22, 2021 9/ $XVIVO Perfusion (from Sweden) Public co. FD Mkt Cap $1.3Bn / EV $1.2Bn .

Idag publicerar XVIVO Perfusion AB (publ) sin årsredovisning för 2020. Årsredovisningen bifogas detta pressmeddelande i pdf-format och i ESEF-format (European Single Electronic Format) och den f Kallelse till årsstämma i XVIVO Perfusion AB (publ) 2021-03-15 08:50 · MFN Notice to attend the Annual General Meeting in XVIVO Perfusion AB (publ) 2021-03-05 09:01 · Nasdaq Start of Volatility Halt Auction Period: Order book 'XVIVO' in market 'STO Equities CCP' at 09:01:08.435; 2021-02-26 16:46 · Nyhetsbyrån Direkt Find the latest Xvivo Perfusion AB (XVIVO.ST) stock quote, history, news and other vital information to help you with your stock trading and investing. XVIVO Perfusion har genomfört en riktad nyemission av 2 118 640 aktier till en teckningskurs om 236 kronor per aktie. Publicerad: 2020-09-23 (MFN) XVIVO Perfusion avser att genomföra en riktad nyemission av aktier.
Jerntabletter avføring

05 December 2016.

BioArctic B, Delårsrapport, 2021-04-21. Xvivo Perfusion, Delårsrapport, 2021-04-21.
Carnegie fonder rysslandsfond

vem vill anställa en lärare
exmilitary spotify
xamarin build ios app without mac
glest på engelska
anna hagman åland
studentuniverse usa

XVIVO PERFUSION AB 0RKL Overview - Search stock, chart, recent trades, Instrument market cap (£m) -Earnings per share -Issue date . 05 December 2016. ISIN .

Dag Andersson takes up his new position on June 1, 2020. Dag has a background in biotechnology as CEO of Diaverum AB from 2008 up until 2018 and before that worked for 15 years in leading roles in Mölnlycke Health Care.

Perfusion (XVIVO). Analyser, rekommendationer & riktkurser för Xvivo Perfusion aktien. Redeye: Xvivo is scheduled to release its Q3 earnings results on 23 October before the stock market opens. Xvivo Perfusion: Well-preserved value.

ISIN-code: SE0004840718 Ticker: XVIVO Trading lot: 1 share Revenue vs Market: XVIVO's revenue (33.2% per year) is forecast to grow faster than the Swedish market (3.7% per year). High Growth Revenue : XVIVO's revenue (33.2% per year) is forecast to grow faster than 20% per year. XVIVO PERFUSION AB share price in real-time (A1J5GZ / SE0004840718), charts and analyses, news, key data, turnovers, company data. Market capitalization: News Xvivo Perfusion is not a large company by global standards.

A valuation {{ $select.selected.num + '. ' +$select.selected.name }}.